gap3ko
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02313376)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparum D6Immunity, active
Plasmodium falciparum D6 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gap3ko
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03168854 | Phase 1 | Jul 6, 2017 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02313376 | Phase 1 | Dec 1, 2014 | University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2017 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1